Gene · 55818
Papers1,506
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,506
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progression. | Front Immunol | 2023 | 37539058 | PubTator, text mining | PubMed |
| Circ_0000235 targets MCT4 to promote glycolysis and progression of bladder cancer by sponging miR-330-5p. | Cell Death Discov | 2023 | 37532687 | PubTator, text mining | PubMed |
| PHF8-GLUL axis in lipid deposition and tumor growth of clear cell renal cell carcinoma. | Sci Adv | 2023 | 37531433 | PubTator, text mining | PubMed |
| Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets. | Signal Transduct Target Ther | 2023 | 37518181 | PubTator, text mining | PubMed |
| The Influence of Single Nucleotide Polymorphisms on Vitamin D Receptor Protein Levels and Function in Chronic Liver Disease. | Int J Mol Sci | 2023 | 37511164 | PubTator, text mining | PubMed |
| Unravelling the Role of P300 and TMPRSS2 in Prostate Cancer: A Literature Review. | Int J Mol Sci | 2023 | 37511059 | PubTator, text mining | PubMed |
| Searching for molecular hypoxia sensors among oxygen-dependent enzymes. | Elife | 2023 | 37494095 | PubTator, text mining | PubMed |
| PHF5A as a new OncoTarget and therapeutic prospects. | Heliyon | 2023 | 37483794 | PubTator, text mining | PubMed |
| Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution. | Front Endocrinol (Lausanne) | 2023 | 37455903 | PubTator, text mining | PubMed |
| Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 Axis. | Int J Mol Sci | 2023 | 37446127 | PubTator, text mining | PubMed |
| PHF5A regulates the expression of the DOCK5 variant to promote HNSCC progression through p38 MAPK activation. | Biol Direct | 2023 | 37434235 | PubTator, text mining | PubMed |
| Application of CRISPR screen in mechanistic studies of tumor development, tumor drug resistance, and tumor immunotherapy. | Front Cell Dev Biol | 2023 | 37427373 | PubTator, text mining | PubMed |
| Oncogenic SRSF3 in health and diseases. | Int J Biol Sci | 2023 | 37416784 | PubTator, text mining | PubMed |
| The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications. | Exp Hematol Oncol | 2023 | 37415251 | PubTator, text mining | PubMed |
| Dynamic de novo heterochromatin assembly and disassembly at replication forks ensures fork stability. | Nat Cell Biol | 2023 | 37414849 | PubTator, text mining | PubMed |
| Corrigendum: KDM3A inhibition ameliorates hyperglycemia-mediated myocardial injury by epigenetic modulation of nuclear factor kappa-B/P65. | Front Cardiovasc Med | 2023 | 37408652 | PubTator, text mining | PubMed |
| Long noncoding RNA (lncRNA) H19: An essential developmental regulator with expanding roles in cancer, stem cell differentiation, and metabolic diseases. | Genes Dis | 2023 | 37397543 | PubTator, text mining | PubMed |
| Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. | Exp Mol Med | 2023 | 37394582 | PubTator, text mining | PubMed |
| Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective. | Exp Mol Med | 2023 | 37394580 | PubTator, text mining | PubMed |
| Lysine 68 Methylation-Dependent SOX9 Stability Control Modulates Chondrogenic Differentiation in Dental Pulp Stem Cells. | Adv Sci (Weinh) | 2023 | 37386801 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55818/papers?page=8